Zacks Investment Research on MSN
Merck & Co., Inc. (MRK) is a trending stock: Facts to know before betting on it
Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...
Before its fifty percent surge, the drug giant was repeatedly telling a story about its future that the market seemed to be ...
Merck & Co., Inc. (NYSE:MRK) is included among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors. On June 24, ...
Merck (NYSE: MRK) closed Tuesday's session down 0.87% at $128.26, breaking a six-session winning streak. The stock had gained 13.62% over the preceding six trading sessions, outperforming the S&P 500, ...
View Merck & Co., Inc. MRK stock quote prices, financial information, real-time forecasts, and company news from CNN.
Mixed stock index futures as tech rebounds: watch Micron earnings, Merck’s Keytruda approval, Wendy’s WSB surge, and ...
Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more than ...
Merck draws attention as healthcare strength, pharma activity, and defensive market rotation place large drugmakers back in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results